Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Centaur Pharma has signed an agreement with Senju Pharma to introduce a formulation of Timolol Long Acting (Glucotim LA) in India in December 2010, as a treatment for glaucoma and other ophthalmologicals disorders.
Subscribe to our email newsletter
Glucotim LA of Centaur Pharma is an original research formulation of Timolol Long Acting developed by Senju.
Centaur Pharma has introduced the vial for the first time in India at just INR45 per vial.
Centaur claims that Glucotim LA shows efficacy equivalent to Timolol BID and is designed for rapid, continuous delivery.